Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
The FASEB Journal (Impact Factor: 5.04). 10/2010; 24(10):3706-19. DOI: 10.1096/fj.09-151159
Source: PubMed


The purpose of this study was to investigate the role of the mutant CUGn RNA in the induction of stress in type 1 myotonic dystrophy (DM1) cells and in the stress-mediated inhibition of protein translation in DM1. To achieve our goals, we performed HPLC-based purification of stress granules (SGs), immunoanalysis of SGs with stress markers TIA-1, CUGBP1, and ph-eIF2, site-specific mutagenesis, and examinations of RNA-protein and protein-protein interactions in myoblasts from control and DM1 patients. The cause-and-effect relationships were addressed in stable cells expressing mutant CUG repeats. We found that the mutant CUGn RNA induces formation of SGs through the increase of the double-stranded RNA-dependent protein kinase (PKR) and following inactivation of eIF2α, one of the substrates of PKR. We show that SGs trap mRNA coding for the DNA repair and remodeling factor MRG15 (MORF4L1), translation of which is regulated by CUGBP1. As the result of the trapping, the levels of MRG15 are reduced in DM1 cells and in CUG-expressing cells. These data show that CUG repeats cause stress in DM1 through the PKR-ph-eIF2α pathway inhibiting translation of certain mRNAs, such as MRG15 mRNA. The repression of protein translation by stress might contribute to the progressive muscle loss in DM1.

14 Reads
  • Source
    • "Activation of the cyclin D3-Cdk4/6 signaling cascade leads to phosphorylation of CELF1 at S302, affecting binding of CELF1 to eIF2α and influencing the rates of translation of several mRNAs (e.g., C/EBPbeta, CDKN1A)[68]. Phosphorylation of CELF1 by eIF2α stress kinases (e.g., PKR and PERK) facilitates binding of CELF1 to eIF2α and TIA1, altering the binding by CELF1 to pro-survival mRNA targets and trigger translational inhibition[69]. CELF1 phosphorylation by AKT kinase pathway at S28 in normal muscle myoblasts regulates the translation of CELF1 target transcripts during myocyte differentiation and murine heart development[70]. In addition, PKCα/β and downstream kinase-dependent phosphorylation of CELF1 at serine 28 (and possibly S52, 178, 179, 241, 300, 302) are involved in proper murine heart development[71]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In response to environmental signals, kinases phosphorylate numerous proteins, including RNA-binding proteins such as the AU-rich element (ARE) binding proteins, and the GU-rich element (GRE) binding proteins. Posttranslational modifications of these proteins lead to a significant changes in the abundance of target mRNAs, and affect gene expression during cellular activation, proliferation, and stress responses. In this review, we summarize the effect of phosphorylation on the function of ARE-binding proteins ZFP36 and ELAVL1 and the GRE-binding protein CELF1. The networks of target mRNAs that these proteins bind and regulate include transcripts encoding kinases and kinase signaling pathways (KSP) components. Thus, kinase signaling pathways are involved in feedback regulation, whereby kinases regulate RNA-binding proteins that subsequently regulate mRNA stability of ARE- or GRE-containing transcripts that encode components of KSP.
    Preview · Article · Jan 2016
  • Source
    • "olved in the splicing of several genes directly implicated in the multisystem phenotype of DM patients , such as cardiac Troponin ( cTNT ) , IR and chloride channel 1 ( CLCN1 ; Osborne et al . , 2009 ) . Overactivation of PKR also inactivates its substrate eIF2α , inhibiting the translation of specific mRNAs , such as the DNA repair factor MRG15 ( Huichalaf et al . , 2010 ) ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Myotonic dystrophy type 1 (DM1 or Steinert’s disease) and type 2 (DM2) are multisystem disorders of genetic origin. Progressive muscular weakness, atrophy and myotonia are the most prominent neuromuscular features of these diseases, while other clinical manifestations such as cardiomyopathy, insulin resistance and cataracts are also common. From a clinical perspective, most DM symptoms are interpreted as a result of an accelerated aging (cataracts, muscular weakness and atrophy, cognitive decline, metabolic dysfunction, etc.), including an increased risk of developing tumors. From this point of view, DM1 could be described as a progeroid syndrome since a notable age-dependent dysfunction of all systems occurs. The underlying molecular disorder in DM1 consists of the existence of a pathological (CTG) triplet expansion in the 3′ untranslated region (UTR) of the Dystrophia Myotonica Protein Kinase (DMPK) gene, whereas (CCTG)n repeats in the first intron of the Cellular Nucleic acid Binding Protein/Zinc Finger Protein 9 (CNBP/ZNF9) gene cause DM2. The expansions are transcribed into (CUG)n and (CCUG)n-containing RNA, respectively, which form secondary structures and sequester RNA-binding proteins, such as the splicing factor muscleblind-like protein (MBNL), forming nuclear aggregates known as foci. Other splicing factors, such as CUGBP, are also disrupted, leading to a spliceopathy of a large number of downstream genes linked to the clinical features of these diseases. Skeletal muscle regeneration relies on muscle progenitor cells, known as satellite cells, which are activated after muscle damage, and which proliferate and differentiate to muscle cells, thus regenerating the damaged tissue. Satellite cell dysfunction seems to be a common feature of both age-dependent muscle degeneration (sarcopenia) and muscle wasting in DM and other muscle degenerative diseases. This review aims to describe the cellular, molecular and macrostructural processes involved in the muscular degeneration seen in DM patients, highlighting the similarities found with muscle aging.
    Full-text · Article · Jul 2015 · Frontiers in Aging Neuroscience
  • Source
    • "Among the mis-splicing events that have been documented [8], splicing reversions occurring in the muscle chloride channel CLCN1 [9], [10], the insulin receptor INSR [11] and BIN1 [12] contribute respectively to myotonia, insulin resistance and muscle weakness. Since MBNL1 has also been implicated in transcription and other aspects of RNA biogenesis [13]–[15], and since CUGBP1 can regulate translation [16], [17], other defects in gene expression are expected. Moreover, the CUG repeat expansion may have other effects on gene expression, as suggested by a study in a CTG repeat-expressing mouse that identified changes in the abundance of many extracellular matrix mRNAs [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: With the goal of identifying splicing alterations in myotonic dystrophy 1 (DM1) tissues that may yield insights into targets or mechanisms, we have surveyed mis-splicing events in three systems using a RT-PCR screening and validation platform. First, a transgenic mouse model expressing CUG-repeats identified splicing alterations shared with other mouse models of DM1. Second, using cell cultures from human embryonic muscle, we noted that DM1-associated splicing alterations were significantly enriched in cytoskeleton (e.g. SORBS1, TACC2, TTN, ACTN1 and DMD) and channel (e.g. KCND3 and TRPM4) genes. Third, of the splicing alterations occurring in adult DM1 tissues, one produced a dominant negative variant of the splicing regulator RBFOX1. Notably, half of the splicing events controlled by MBNL1 were co-regulated by RBFOX1, and several events in this category were mis-spliced in DM1 tissues. Our results suggest that reduced RBFOX1 activity in DM1 tissues may amplify several of the splicing alterations caused by the deficiency in MBNL1.
    Full-text · Article · Sep 2014 · PLoS ONE
Show more